Skip to main content
OpenTrials

Clinical trial condition

Mononegavirales Infections

Explore clinical trials studying Mononegavirales Infections. Study availability and eligibility vary by location and protocol.

536 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Mononegavirales Infections trial results

Completed

PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response

NCT03098862

Conditions
Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations
  • PREVAIL C. H. Rennie Hospital Kalkata, Liberia
  • PREVAIL JFK Medical Center Monrovia, Liberia
  • PREVAIL Redemption Hospital Monrovia, Liberia
  • PREVAIL Duport Road Clinic Paynesville, Liberia
View Trial Details
Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

NCT03814590

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Jacksonville, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
  • GSK Investigational Site Lenexa, Kansas, United States
View all 21 locations
View Trial Details
Completed

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

NCT03636906

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Nampa, Idaho, United States
  • GSK Investigational Site Louisville, Kentucky, United States
  • GSK Investigational Site Baltimore, Maryland, United States
View all 37 locations
View Trial Details

Related conditions